Michal Gilon Ohev-Zion is the CEO and Co-Founder of Everly Bio, where she leverages novel molecular insights and computational biology to advance fertility care. With a strong background in research and development, she has held senior roles such as VP of Research & Development at Anchiano Therapeutics and BioCanCell Therapeutic Inc, focusing on targeted cancer therapies. Her academic foundation includes a PhD in Molecular and Developmental Biology from The Hebrew University of Jerusalem.
Professional Experience
18y
Role Type
Engineering8y
Leadership8y
Data & Research5.5y
Industry
Education (Non-Tech)10y+
Health Tech & Life Sciences10y+
Other3y
Organization Type
Academia & Research10y+
Corporate / Enterprise7.5y
Other4y
Startup3.5y
Career-Linked Companies in Finder
Companies from this member’s experience that have profiles in Finder